Wicinski_2020_Pharmaceuticals.(Basel)_13_

Reference

Title : Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury - Wicinski_2020_Pharmaceuticals.(Basel)_13_
Author(s) : Wicinski M , Wodkiewicz E , Gorski K , Walczak M , Malinowski B
Ref : Pharmaceuticals (Basel) , 13 : , 2020
Abstract : Wicinski_2020_Pharmaceuticals.(Basel)_13_
ESTHER : Wicinski_2020_Pharmaceuticals.(Basel)_13_
PubMedSearch : Wicinski_2020_Pharmaceuticals.(Basel)_13_
PubMedID: 33187206

Related information

Citations formats

Wicinski M, Wodkiewicz E, Gorski K, Walczak M, Malinowski B (2020)
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury
Pharmaceuticals (Basel) 13 :

Wicinski M, Wodkiewicz E, Gorski K, Walczak M, Malinowski B (2020)
Pharmaceuticals (Basel) 13 :